GSK plc (GSK) — Stock Price, Chart & Analysis
GSK plc (GSK) is a Healthcare stock currently trading at $50.72, down 0.70% on the day. It carries a market capitalization of $101.58B and a trailing P/E ratio of 16.20. Over the past 52 weeks, GSK has traded between $39.29 and $61.70. GSK plc pays a dividend yielding 3.6%. View the live GSK chart, technical opinion, analyst ratings, fundamentals and latest news below.
GSK plc (GSK) key data
| Price | $50.72 |
| Change (today) | -0.70% |
| Previous close | $51.08 |
| Market cap | $101.58B |
| P/E ratio (TTM) | 16.20 |
| EPS (TTM) | $3.13 |
| Dividend yield | 3.6% |
| 52-week high | $61.70 |
| 52-week low | $39.29 |
| Beta | 0.29 |
| Avg. volume | 3.59M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about GSK plc (GSK)
How much does one share of GSK plc cost?
As of the latest update, one share of GSK plc (GSK) trades at $50.72 (-0.70% today).
What is GSK plc's market cap?
GSK plc has a market capitalization of approximately $101.58B.
What is GSK plc's P/E ratio?
GSK plc has a trailing price-to-earnings (P/E) ratio of 16.20.
What is GSK plc's earnings per share (EPS)?
GSK plc's trailing twelve-month EPS is $3.13.
Does GSK plc pay a dividend?
Yes — GSK plc pays a dividend with a yield of 3.6% ($1.82 per share annually).
What is GSK plc's 52-week trading range?
Over the past year, GSK has traded between $39.29 and $61.70.
What is the analyst price target for GSK plc?
The mean analyst price target for GSK plc is $59.33. This is informational only and not investment advice.
Latest GSK plc (GSK) news
- GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take ShapeNews · Sep 23, 2026
- ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product StrategyNews · Sep 21, 2026
- GSK Inks $750M Deal to Add Experimental Blood Cancer TherapyNews · Sep 15, 2026
- GSK Cuts 641 Jobs in Vaccine Manufacturing RestructuringNews · Sep 15, 2026
- GSK splashes up to $750m on experimental cancer therapyNews · Sep 15, 2026
- GSK Presents Jideytro Data for Potential Use in First-Line NSCLCNews · Sep 14, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live GSK dashboard…